Surgical Resection After Downsizing of Colorectal Liver Metastasis in the Era of Bevacizumab
- 1 August 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (22), 4853-4855
- https://doi.org/10.1200/jco.2005.23.754
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Tumor Progression While on ChemotherapyAnnals of Surgery, 2004
- Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by ChemotherapyAnnals of Surgery, 2004
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR StudyJournal of Clinical Oncology, 2004
- Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liverBritish Journal of Surgery, 2003
- Angiogenesis-Independent Endothelial Protection of Liver: Role of VEGFR-1Science, 2003
- Vascular Endothelial Growth Factor and Angiopoietin in Liver RegenerationBiochemical and Biophysical Research Communications, 2001
- Increased Expressions of Vascular Endothelial Growth Factor and Its Receptors,flt-1 andKDR/flk-1, in Regenerating Rat LiverBiochemical and Biophysical Research Communications, 1996
- A Method for the Detailed Assessment of the Appropriateness of Medical TechnologiesInternational Journal of Technology Assessment in Health Care, 1986